These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 26226887)
1. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis. Cheng H; Long F; Jaiswar M; Yang L; Wang C; Zhou Z Sci Rep; 2015 Jul; 5():11026. PubMed ID: 26226887 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Huang QT; Zhou L; Zeng WJ; Ma QQ; Wang W; Zhong M; Yu YH Cell Physiol Biochem; 2017; 41(6):2411-2418. PubMed ID: 28467978 [TBL] [Abstract][Full Text] [Related]
4. Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies. Wu S; Zhao X; Wang Y; Zhong Z; Zhang L; Cao J; Ai K; Xu R Cell Physiol Biochem; 2018; 46(4):1352-1364. PubMed ID: 29689562 [TBL] [Abstract][Full Text] [Related]
5. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients. Zhou Y; Wei Q; Fan J; Cheng S; Ding W; Hua Z Clin Chim Acta; 2018 Apr; 479():181-189. PubMed ID: 29407690 [TBL] [Abstract][Full Text] [Related]
6. Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma. Ben Q; An W; Wang L; Wang W; Yu L; Yuan Y Pancreas; 2015 Apr; 44(3):471-7. PubMed ID: 25423560 [TBL] [Abstract][Full Text] [Related]
7. The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis. Xu ZG; Ye CJ; Liu LX; Wu G; Zhao ZX; Wang YZ; Shi BQ; Wang YH Biomark Med; 2018 Feb; 12(2):189-199. PubMed ID: 29327595 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis. Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis. Zhang X; Zhang W; Feng LJ PLoS One; 2014; 9(11):e111906. PubMed ID: 25401500 [TBL] [Abstract][Full Text] [Related]
10. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients. Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962 [TBL] [Abstract][Full Text] [Related]
11. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies. Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive assessment of the prognosis of pancreatic cancer: peripheral blood neutrophil-lymphocyte ratio and immunohistochemical analyses of the tumour site. Takakura K; Ito Z; Suka M; Kanai T; Matsumoto Y; Odahara S; Matsudaira H; Haruki K; Fujiwara Y; Saito R; Gocho T; Nakashiro K; Hamakawa H; Okamoto M; Kajihara M; Misawa T; Ohkusa T; Koido S Scand J Gastroenterol; 2016; 51(5):610-7. PubMed ID: 26679084 [TBL] [Abstract][Full Text] [Related]
13. Pretreatment blood neutrophil/lymphocyte ratio is associated with metastasis and predicts survival in patients with pancreatic cancer. Guo J; Wu M; Guo L; Zuo Q Bull Cancer; 2018 Feb; 105(2):146-154. PubMed ID: 29290332 [TBL] [Abstract][Full Text] [Related]
14. The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis. Tang X; Du P; Yang Y Int J Clin Oncol; 2017 Oct; 22(5):817-825. PubMed ID: 28752351 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-Lymphocyte Ratio Is a Potential Prognostic Biomarker in Patients with Ovarian Cancer: A Meta-Analysis. Chen S; Zhang L; Yan G; Cheng S; Fathy AH; Yan N; Zhao Y Biomed Res Int; 2017; 2017():7943467. PubMed ID: 28815182 [TBL] [Abstract][Full Text] [Related]
16. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies. Yang Z; Gu JH; Guo CS; Li XH; Yang WC Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis. Tang L; Li X; Wang B; Luo G; Gu L; Chen L; Liu K; Gao Y; Zhang X PLoS One; 2016; 11(4):e0153981. PubMed ID: 27096158 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-analysis. Zhan H; Ma JY; Jian QC Clin Chim Acta; 2018 Sep; 484():136-140. PubMed ID: 29856976 [TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis. Cao J; Zhu X; Zhao X; Li XF; Xu R PLoS One; 2016; 11(7):e0158770. PubMed ID: 27368058 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis. Bowen RC; Little NAB; Harmer JR; Ma J; Mirabelli LG; Roller KD; Breivik AM; Signor E; Miller AB; Khong HT Oncotarget; 2017 May; 8(19):32171-32189. PubMed ID: 28418870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]